Abstract
In order to reveal the underlying retinal pathology leading to dysfunction in vigabatrin-exposed patients, we aimed to evaluate the inner retinal layers encompassing ganglion cell complex (GCC) layer and inner plexiform layer with new generation optic coherence tomography (OCT). Fourteen patients with epilepsy and exposure to vigabatrin and 12 clinically normal individuals, constituting the control group, were included. Retinal images were obtained using spectral-domain OCT (Optovue RTVue Fourier domain). Nasal and superior quadrants of retinal nerve fiber layer (RNFL) were found to be significantly lower in the patient group compared to the controls (p < 0.01). No significant difference was shown in the thickness of GCC layer (p > 0.05). Foveal thickness was significantly higher in the patient group (p: 0.006), but no significant difference was found in perifoveal and parafoveal regions between groups (p > 0.05). The thickness of RNFL was found to be lower in vigabatrin-exposed patients without any reduction in GCC layer in the macular region. However, foveal thickness was found to be significantly higher compared to perifoveal and parafoveal macular regions in vigabatrin-exposed patients. In conclusion, OCT revealed reduced thickness of RNFL without any reduction in ganglion cell layer in our study. The objective quantitative assessment of OCT is a practical noninvasive method and it can have role in future monitoring of these patients.
Similar content being viewed by others
References
Cross-Disorder Phenotype Group of the Psychiatric GWAS Consortium, Craddock N, Kendler K, Neale M, Nurnberger J, Purcell S, Rietschel M, Perlis R, Santangelo SL, Schulze TG, Smoller JW, Thapar A (2009) Dissecting the phenotype in genome-wide association studies of psychiatric illness. Br J Psychiatry 195(2):97–99
Hardus P, Verduin WM, Berendschot TT, Kamermans M, Postma G, Stilma JS et al (2001) The value of electrophysiology results in patients with epilepsy and vigabatrin associated visual field loss. Acta Ophthalmol Scand 79(2):169–174
Sills GJ, Butler E, Forrest G, Ratnaraj N, Patsalos PN, Brodie MJ (2003) Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 44(7):886–892
Ravindran J, Blumbergs P, Crompton J, Pietris G, Waddy H (2001) Visual field loss associated with vigabatrin: pathological correlations. J Neurol Neurosurg Psychiatry 70:787–789
Hawker MJ, Astbury NJ (2008) The ocular side effects of vigabatrin (Sabril): information and guidance for screening. Eye (Lond) 22(9):1097–1098
Harding GF, Wild JM, Robertson KA, Lawden MC, Betts TA, Barber C et al (2000) Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia 41(11):1420–1431
Durnian JM, Clearkin LG (2008) Retinal nerve fibre layer characteristics with vigabatrin-associated visual field loss—could scanning laser polarimetry aid diagnosis? Eye (Lond) 22(4):559–563
Eke T, Talbot JF, Lawden MC (1997) Severe persistent visual field constriction associated with vigabatrin. BMJ 314:180–181
Vizzeri G, Weinreb RN, Gonzalez-Garcia AO, Bowd C, Medeiros FA, Sample PA et al (2009) Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness. Br J Ophthalmol 93(6):775–781
Clayton LM, Dévilé M, Punte T, Kallis C, de Haan GJ, Sander JW et al (2011) Retinal nerve fiber layer thickness in vigabatrin-exposed patients. Ann Neurol 69(5):845–854
Wild JM, Robson CR, Jones AL, Cunliffe IA, Smith PE (2006) Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 47(3):917–924
Buncic JR, Westall CA, Panton CM, Munn JR, MacKeen LD, Logan WJ (2004) Characteristic retinal atrophy with secondary “inverse” optic atrophy identifies vigabatrin toxicity in children. Ophthalmology 111(10):1935–1942
Lawthom C, Smith PE, Wild JM (2009) Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity. Ophthalmology 116:565–571
Jammoul F, Dégardin J, Pain D, Gondouin P, Simonutti M, Dubus E et al (2010) Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. Mol Cell Neurosci 43(4):414–421
Wang QP, Jammoul F, Duboc A, Gong J, Simonutti M, Dubus E et al (2008) Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina. Eur J Neurosci 27(8):2177–2187
Izumi Y, Ishikawa M, Benz AM, Izumi M, Zorumski CF, Thio LL (2004) Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. Epilepsia 45(9):1043–1048
Krauss GL, Johnson MA, Miller NR (1998) Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 50:614–618
Wilson EA, Brodie MJ (1997) Severe persistent visual field constriction associated with vigabatrin [letter]. BMJ 314:1693
Duboc A, Hanoteau N, Simonutti M, Rudolf G, Nehlig A, Sahel JA et al (2004) Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol 55(5):695–705
Hébert-Lalonde N, Carmant L, Major P, Roy MS, Lassonde M, Saint-Amour D (2016) Electrophysiological evidences of visual field alterations in children exposed to vigabatrin early in life. Pediatr Neurol 59:47–53
Coupland SG, Zackon DH, Leonard BC, Ross TM (2001) Vigabatrin effect on inner retinal function. Ophthalmology 108(8):1493–1496
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Tuğcu, B., Bitnel, M.K., Kaya, F.S. et al. Evaluation of inner retinal layers with optic coherence tomography in vigabatrin-exposed patients. Neurol Sci 38, 1423–1427 (2017). https://doi.org/10.1007/s10072-017-2971-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-2971-0